ARROWHEAD PHARMACEUTICALS IN (ARWR) Institutional Ownership Changes & 13F Activity

ARROWHEAD PHARMACEUTICALS IN (ARWR). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC and Sequoia Financial Advisors.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCBuy805,1951,036,495$64,988,237
Q1 2026Sequoia Financial AdvisorsSell-363,602$225,846
Q4 2025Sequoia Financial AdvisorsBuy3,6383,638$241,543
Q3 2024Renaissance Technologies LLCBuy109,300231,300$4,480,281
Q4 2023Renaissance Technologies LLCSell-259,500122,000$3,733
Q3 2023Renaissance Technologies LLCSell-3,400381,500$10,251
Q2 2023Renaissance Technologies LLCBuy92,100384,900$13,726
Q1 2023Renaissance Technologies LLCSell-201,000292,800$7,437
Q4 2022Renaissance Technologies LLCSell-261,600493,800$20,029
Q3 2022Renaissance Technologies LLCBuy314,400755,400$24,966
Q2 2022Renaissance Technologies LLCBuy60,700441,000$15,528
Q1 2022Renaissance Technologies LLCBuy326,200380,300$17,490
Q3 2021Renaissance Technologies LLCSell-125,10054,100$3,377
Q2 2021Renaissance Technologies LLCSell-62,400179,200$14,841
Q1 2021Renaissance Technologies LLCSell-424,800241,600$16,020
Q1 2020Renaissance Technologies LLCSell-55,900666,400$19,172
Q4 2019Renaissance Technologies LLCBuy64,700722,300$45,815
Q3 2019Renaissance Technologies LLCSell-131,200657,600$18,531
Q2 2019Renaissance Technologies LLCBuy618,400788,800$20,903
Q1 2019Renaissance Technologies LLCSell-203,764170,400$3,127
Q2 2017Renaissance Technologies LLCBuy374,164374,164$606

Frequently asked questions about ARWR activity

  • Which institutional owners are buying ARWR?

    Institutional owners buying ARWR include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ARWR activity?

    "Buy" means an investor increased their reported position in ARWR compared to the prior reporting period. This reflects growing exposure to ARROWHEAD PHARMACEUTICALS IN (ARWR) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ARWR increasing?

    Institutional interest in ARWR can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related ARWR Institutional Insights